Main Article Content
Methods: A total of forty-five isolates of M. tuberculosis were tested for susceptibility to isoniazid (INH), rifampin (RMP), ethambutol (EMB), and streptomycin (SM). The strains were isolated in Montería, during 2003 and 2005. The agreement between the two assays mentioned was estimated by the Kappa test.
Results: There were thirty-eight strains with identical results while 7 had discrepant results with both methods. The overall resistance to antituberculosis drugs were 33.3% y 31.1% for manual MGIT and PM, respectively. MDR was 5 (11.1%) by PM and 4 (8.8%) by manual MGIT. The agreement between MGIT AST and PM was 95.5% for all drug tested and overall kappa value 0.8374. Two discrepancies were found in each drug; with INH and RIF (one false resistant and one false susceptible). STR and EMB (two false susceptibles). Turnaround times were 5 to 8 days (median, 6.5 days) for MGIT and 20 to 25 days for MP.
Conclusions: These preliminary data show a good level of agreement between manual MGIT AST SIRE and MP. Also MGIT is a rapid, easy and efficient method for the drug susceptibility testing of M. tuberculosis.
- José Laguado, Nelson Alvis, Salim Máttar, Investigación de un brote de fiebre de origen desconocido en una localidad colombiana del Caribe. , Colombia Medica: Vol. 36 No. 4 (2005)
- Jorge Miranda, Rodrigo Ríos, Andrea Clavijo, Carlos Chacón, Salim Mattar, Preliminary survey of antimicrobial susceptibility and genetic variability of Mycobacterium tuberculosis isolates from Colombian Caribbean. , Colombia Medica: Vol. 37 No. 4 (2006)
- Juan Camilo Calderón, Jaime E. Castellanos, Salim Mattar, Correspondencia. , Colombia Medica: Vol. 37 No. 2 (2006)
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use